D-Wave Quantum Inc.

New York Stock Exchange
Back to all articles
Slightly Bullish +25

D-Wave Quantum (QBTS) Stock Plunges 40% in 2026: Will $100M Federal Funding Spark a Recovery?

AI-generated analysis

📉 QBTS shares plummeted approximately 40% year-to-date in 2026, trading at $16.41 after a 2.50% daily decline.

💰 The company secured a definitive agreement for up to $100M in non-dilutive CHIPS and Science Act funding from the U.S. Department of Commerce.

📉 Second quarter 2026 revenue totaled $3.1M, falling short of analyst expectations of $4M and marking a marginal year-over-year decrease.

⚠️ Management attributed the revenue miss to timing issues with customer contracts that did not materialize or finalize within the quarter.

🤝 D-Wave faces an expanding divide from competitor IonQ, which delivered robust earnings while D-Wave struggles with consistent revenue generation.

📈 Analyst consensus shows a Strong Buy rating with a $35.46 average target price, representing potential upside of approximately 116%.

🎤 CEO Dr. Alan Baratz characterized the federal funding as evidence of commitment to advancing quantum technology commercialization beyond academic research.

🚀 The non-dilutive capital structure protects current shareholders while providing third-party validation during market uncertainty.

🌐 D-Wave will present its quantum computing dual-platform approach at Quantum World Congress 2026 in College Park, Maryland.

🔬 Chief Science Officer Robert Schoelkopf will discuss advancements in hardware-based erasure detection to decrease costs and complexity of error correction.

Bullish Signals
  • D-Wave secured a definitive agreement with the U.S. Department of Commerce for up to $100M in non-dilutive CHIPS and Science Act funding.
  • This capital comes without dilution, meaning D-Wave won't need to create additional shares to access these funds, protecting current shareholders.
  • The federal funding is expected to accelerate research and development initiatives and potentially strengthen credibility with prospective enterprise clients.
  • Analyst consensus shows a Strong Buy rating with a $35.46 average target price, representing potential upside of approximately 116% from the current trading price.
  • D-Wave will showcase its quantum computing dual-platform approach at Quantum World Congress 2026, highlighting real-world commercial applications for its annealing systems.
Risk Factors
  • QBTS shares have plummeted approximately 40% year-to-date in 2026, trading at $16.41 as of Tuesday's close.
  • Second quarter 2026 revenue totaled $3.1M, falling short of analyst expectations of $4M and marking a marginal year-over-year decrease.
  • The company faces significant headwinds in 2026 with shares declining roughly 17% over the past 30 days following Q2 earnings disappointment.
  • D-Wave's revenue stream remains lumpy and dependent on a limited customer base, creating unpredictability in quarterly performance.
Full Analysis
D-Wave Quantum (QBTS) shares have declined approximately 40% year-to-date in 2026, trading at $16.41 following a disappointing second-quarter revenue report of $3.1 million that missed analyst expectations of $4 million. The company faces significant headwinds as its revenue stream remains lumpy and dependent on a limited customer base, contrasting with competitors like IonQ who achieved robust growth during the same period. To address these challenges, D-Wave secured a definitive agreement with the U.S. Department of Commerce for up to $100 million in non-dilutive funding under the CHIPS and Science Act. CEO Dr. Alan Baratz highlighted that this capital will accelerate research and development without diluting current shareholders, providing third-party validation during a period of market uncertainty. The company plans to showcase its dual-platform approach at the Quantum World Congress 2026 in College Park, Maryland, focusing on real-world commercial applications for its annealing systems and updates to its gate-model platform. Analyst consensus remains bullish with a Strong Buy rating and an average price target of $35.46, suggesting potential upside despite recent stock volatility.